EL
NTLA icon

EMFO LLC’s Intellia Therapeutics NTLA Stock Holding History

EMFO LLC’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$8.73K Hold
390
– – 0.01% 232
2024
Q1 		$10.7K Hold
390
– – 0.01% 226
2023
Q4 		$11.9K Hold
390
– – 0.01% 220
2023
Q3 		$12.3K Hold
390
– – 0.01% 230
2023
Q2 		$15.9K Hold
390
– – 0.01% 221
2023
Q1 		$14.5K Hold
390
– – 0.01% 229
2022
Q4 		$13.6K Hold
390
– – 0.01% 219
2022
Q3 		$22K Hold
390
– – 0.02% 214
2022
Q2 		$20K Hold
390
– – 0.02% 223
2022
Q1 		$28K Hold
390
– – 0.03% 221
2021
Q4 		$46K Hold
390
– – 0.04% 206
2021
Q3 		$52K Hold
390
– – 0.05% 205
2021
Q2 		$63K Buy
+390
New +$30.4K 0.06% 184

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EMFO LLC's NTLA Position: Q2 2024 in Review

EMFO LLC held its Intellia Therapeutics (NTLA) position steady in Q2 2024 at 390 shares worth $8.73K. The position accounts for 0.01% of the portfolio, ranked #232.

EMFO LLC first reported a position in NTLA in Q2 2021 and has held it in 13 quarters since. The position peaked at $63K in Q2 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q2 2024.

  • EMFO LLC held 390 shares of Intellia Therapeutics worth $8.73K as of Q2 2024.
  • EMFO LLC left its Intellia Therapeutics share count unchanged in Q2 2024.
  • Intellia Therapeutics made up 0.01% of EMFO LLC's portfolio in Q2 2024, its #232 holding.
  • EMFO LLC first reported a position in Intellia Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Intellia Therapeutics position peaked at $63K in Q2 2021.
  • 290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.